{"brief_title": "Compassionate Use of Stanate (TM) [Stannsoporfin]", "brief_summary": "The purpose of this protocol is to make Stanate (TM) [stannsoporfin, tin-mesoporphyrin] available to infants who meet the following criteria: 1. the infant has a very high level of bilirubin without an adequate clinical response to phototherapy; 2. the infant requires an exchange transfusion; and 3. the family refuses to allow the administration of blood products, particularly on religious grounds, such as within the Jehovah's Witness community.", "condition": ["Neonatal Jaundice", "Hyperbilirubinemia"], "intervention_type": ["Drug"], "intervention_name": ["Stanate (TM) [stannsoporfin, tin-mesoporphyrin]"], "description": ["Treatment with 4.5 mg/kg"], "criteria": "- Term or near term neonate - Elevated serum bilirubin - Failing phototherapy - Requires exchange transfusion - Family refuses exchange transfusion on religious grounds", "gender": "All", "minimum_age": "N/A", "maximum_age": "1 Week", "healthy_volunteers": "No", "keyword": "neonatal hyperbilirubinemia", "mesh_term": ["Jaundice", "Hyperbilirubinemia", "Jaundice, Neonatal", "Tin mesoporphyrin"], "id": "NCT00076960"}